跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Risedronate Mevon film-coated tablets 35mg - HSA Drug Approval Details
Approvals
/
HSA
/
Risedronate Mevon film-coated tablets 35mg
Approved
THERAPEUTIC
Risedronate Mevon film-coated tablets 35mg
Pharmathen S.A. (GREECE)
🇸🇬 Health Sciences Authority
Approval Date
May 14, 2010
Approval ID
b61bdb41d1a86088
Company
Pharmathen S.A. (GREECE)
Type
Therapeutic
Approval Details
Approval Id
b61bdb41d1a86088
Drug Name
Risedronate Mevon film-coated tablets 35mg
Product Name
Risedronate Mevon film-coated tablets 35mg
Approval Number
SIN13798P
Approval Date
2010-05-14
Registrant
NOVEM HEALTHCARE PTE LTD
Licence Holder
NOVEM PHARMA PRIVATE LIMITED
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
TABLET, FILM COATED
Route Of Administration
ORAL
Atc Code
M05BA07
Atc Item Name
risedronic acid
Pharma Manufacturer Name
NOVEM PHARMA PRIVATE LIMITED
Active Ingredients
RISEDRONATE SODIUM HEMIPENTAHYDRATE 40.17 mg EQV RISEDRONATE SODIUM
35 mg
RISEDRONATE SODIUM HEMIPENTAHYDRATE 40.17 MG EQV RISEDRONATE SODIUM
35 MG
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
May 14, 2010
Approval ID
b61bdb41d1a86088
Type
Therapeutic
Back to HSA Approvals
